Proteome Sciences plc
PRM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £10 | £13 | £11 | £19 |
| - Cash | £1 | £2 | £4 | £2 |
| + Debt | £15 | £13 | £12 | £12 |
| Enterprise Value | £23 | £25 | £19 | £28 |
| Revenue | £5 | £5 | £23,736 | £22,593 |
| % Growth | -2.8% | -100% | 5.1% | – |
| Gross Profit | £1 | £2 | £5 | £3 |
| % Margin | 13.7% | 32.8% | 0% | 0% |
| EBITDA | -£2 | -£1 | £2 | £1 |
| % Margin | -31% | -22.6% | 0% | 0% |
| Net Income | -£3 | -£2 | £1 | £0 |
| % Margin | -69.7% | -48.6% | 0% | 0% |
| EPS Diluted | -0.012 | -0.008 | 0.004 | 0 |
| % Growth | -38.6% | -293% | 2,050% | – |
| Operating Cash Flow | -£1 | -£0 | £3,882 | £10,522 |
| Capital Expenditures | -£0 | -£0 | -£1,746 | -£1,720 |
| Free Cash Flow | -£1 | -£1 | £2,136 | £8,802 |